Clarity Pharmaceuticals Ltd (cu6) Logo

Clarity Pharmaceuticals Ltd (CU6)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CU6 ASX Chart

Snapshot

Clarity Pharmaceuticals Ltd (CU6) is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company provides innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +508.23%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 266 of 2,383
Sector Rank 15 of 227

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MSB / PNV / REG
EPS -$0.118
DPS $0.00
Book Value Per Share $0.222

Broker Consensus

CU6 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Eveleigh NSW 2015
Website www.claritypharmaceuticals.com
Registry Link Market Services
Auditor Grant Thornton Audit Pty Ltd
Date Listed 25 Aug 2021

Upcoming Calendar (Forecasted)

Date Event
22/08/2024 Report (Prelim)
27/09/2024 Report (Annual)
27/02/2025 Report (Interim)

Former Company Names

  • Clarity Pharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CU6 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/05/24 Robert Thomas Buy +7,575 $4.26 $32,291 On-market trade
20/05/24 Robert Thomas Buy +8,333 $4.28 $35,706 On-market trade
29/04/24 Robert Thomas Issued 17,425 $2.55 $44,433 Rights issue
29/04/24 Robert Thomas Issued 16,667 $2.55 $42,500 Rights issue
21/03/24 Thomas Ramdahl Buy +400,000 $0.605 $242,000 Exercise of options
21/03/24 Thomas Ramdahl Exercise 400,000 $0.605 $242,000 Exercise of options
12/12/23 Alan Taylor Issued 1,764,981 $0.904 $1,596,400 Issue of options
12/12/23 Colin Biggin Issued 928,988 $0.905 $840,846 Issue of options
16/02/23 Colin Biggin Buy +287,208 $0.220 $63,185 Exercise of options
16/02/23 Colin Biggin Exercise 400,000 $0.158 $63,185 Exercise of options
08/12/22 Colin Biggin Issued 837,855 $0.804 $673,704 Issue of options
08/12/22 Alan Taylor Issued 1,083,226 $0.804 $871,003 Issue of options
01/07/22 Colin Biggin Buy +200,000 $0.540 $108,000 Exercise of options
01/07/22 Colin Biggin Exercise 200,000 $0.540 $108,000 Exercise of options
22/06/22 Charles O'Bryan-Tear Buy +120,000 $0.445 $53,400 On-market trade
31/05/22 Thomas Ramdahl Buy +120,000 $0.483 $57,960 On-market trade
26/05/22 Robert Thomas Buy +100,000 $0.439 $43,905 On-market trade
24/12/21 Colin Biggin Issued 200,000 $0.750 $150,000 Exercise of options
24/12/21 Colin Biggin Exercise 200,000 $0.750 $150,000 Exercise of options

Director Interests

The current holdings of CU6 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Robert Thomas 20/05/2024 575,000 600,000 N/A N/A
Thomas Ramdahl 21/03/2024 520,000 N/A 200,000 N/A
Colin Biggin 12/12/2023 1,801,304 N/A 5,566,843 N/A
Alan Taylor 12/12/2023 N/A 14,066,660 5,648,207 N/A
Rosanne Robinson 24/08/2023 N/A N/A 200,000 N/A
Christopher Roberts 24/08/2023 N/A 17,911,280 200,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 20, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Tm Ventures Pty Ltd 18,788,460 7.18%
Cabbit Pty Ltd Atf Robwill Trust 17,911,280 6.84%
National Nominees Limited 16,737,583 6.39%
A.C.N. 136 437 913 Pty Ltd Atf The Taylor Family A/C 13,266,660 5.07%
BNP Paribas Noms Pty Ltd 10,077,537 3.85%
Argo Investments Limited 9,247,447 3.53%
UBS Nominees Pty Ltd 8,176,111 3.12%
Yarrawah Pty Ltd Atf Peter Henderson P/L S/F A/C 7,803,450 2.98%
Vantres Pty Ltd Atf Asten Superannuation Fund 7,487,340 2.86%
Charles Waite Morgan 6,900,041 2.64%
Boorris Pty Ltd Atf Boorris Trust 6,065,800 2.32%
Moore Family Nominee Pty Ltd Atf Moore Family Super Fund 5,800,000 2.21%
Citicorp Nominees Pty Limited 5,725,451 2.19%
Smarter Capital Pty Ltd 5,004,543 1.91%
Kylaco Pty Ltd 3,896,280 1.49%
Australian Nuclear Science And Technology Organisation 3,599,920 1.37%
Pacific Custodians Pty Limited 3,201,408 1.22%
Wyargine Holdings Pty Ltd Atf Shellcove Super Fund 3,116,000 1.19%
Um Commercialisation Pty Ltd 2,946,500 1.13%
Eight Pagodas Pty Ltd Atf Eight Pagodas Superannuation Fund 2,768,320 1.06%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 385 594 284 550 198 2,011

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
A.C.N. 136 437 913 Pty Ltd 20/09/2023 13,266,660 5.07
Cabbit Pty Ltd 08/04/2024 17,911,280 5.85
TM Ventures Pty Ltd 08/04/2024 18,788,460 6.13

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
08-04-24 Alan John Taylor 14,066,660 5.49 --
29-11-23 Charles Waite Morgan 13,593,040 5.19 --
01-09-23 Charles Waite Morgan 5,000,000 7.26 5.19
01-09-23 Matthew John Harris 14,078,620 5.50 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.700 30 June
2022 $0.510 30 June
CU6 Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.